Cited by 139Pharmacy and Medical PracticesDiabetes Management and EducationPharmaceutical Practices and Patient Outcomes

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial: Effectiveness of a pharmacist intervention in diabetes care

Open access
Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J.-P., Giri, M.·2011·Journal of Clinical Pharmacy and Therapeutics

Abstract

WHAT IS KNOWN AND OBJECTIVE: There is little evidence from well-designed randomized controlled trials of the impact of community pharmacist intervention on the clinical management of patients with type 2 diabetes. It is also not known how sustainable any observed effects on glycaemic control are, over time. This study was initiated to address both these issues. METHODS: A 6-month, randomized, controlled parallel-group trial in 66 community pharmacies was conducted in Belgium. Patients were randomly assigned to receive usual pharmacist care (n = 135) or a predefined pharmacist intervention (n = 153). The intervention mainly focused on correct medication use, medication adherence and healthy lifestyle promotion. Primary outcome was glycaemic control, as measured by fasting plasma glucose and HbA1c. Sustainability of changes in glycaemic control was assessed by additional glucose measurements 18 months after the end of the study. RESULTS AND DISCUSSION: The intervention significantly reduced HbA1c (between-group difference: 0·5%, P = 0.009). The largest impact on HbA1c was observed when pharmacotherapy changes (i.e., type and/or dose of hypoglycaemic agents) initiated by the physician were sustained with pharmaceutical care: HbA1c was reduced by 1·05% in the intervention group, whose medication was changed, compared with a reduction of 0·02% in the therapy-modification only, group. It was also found that the diabetes education program resulted in improved self-management and better knowledge of diabetes. Eighteen months after the end of the formal study period, the mean HbA1c of the intervention group did not differ significantly from the control group (7·4% vs. 7·2%). WHAT IS NEW AND CONCLUSION: This study provides new evidence, from a randomized controlled trial, of the beneficial effect of community pharmacist intervention in the clinical management of type 2 diabetic patients. However, questions remain about the sustainability of the observed improvements.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2710.2010.01218.x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 21 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J.-P., & Giri, M.
Affiliations
  • Ghent University (BE)
  • Ghent University Hospital (BE)
Venue
Journal of Clinical Pharmacy and Therapeutics
Publisher
Wiley
Published
2010-12-08
Volume
36
Issue
5
Pages
602-613
ISSN
0269-4727 (ISSN-L)
OpenAlex
W1907109187
Cited by
139
References
21
Citations by year
2026: 2 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 15 · 2017: 9 · 2016: 8 · 2015: 15 · 2014: 11 · 2013: 9 · 2012: 5
FWCI
4.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Pharmacy and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Funders
  • American Diabetes Association
  • Universiteit Gent
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
type 2 diabetes, community pharmacy, pharmacist intervention, pharmaceutical care, glycemic control, HbA1c, medication adherence, medication use, antidiabetic drugs, diabetes education, self-management, healthy lifestyle promotion
MeSH terms
Adult, Aged, Aged, 80 and over, Belgium, Blood Glucose, Community Pharmacy Services, Diabetes Mellitus, Type 2, Female, Health Services Research, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Life Style, Male, Middle Aged, Patient Compliance, Patient Education as Topic, Pharmacies, Pharmacists, Drug Prescriptions, Self Care, Time Factors, Treatment Outcome, Disease Management, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review